Instrumental variable methods in comparative safety and effectiveness research

Pharmacoepidemiology and Drug Safety

Volumn 19, Issue 6, 2010, Pages 537-554

  Brookhart, M Alan ^a,b   Rassen, Jeremy A ^a   Schneeweiss, Sebastian ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b IL   (United States)

Author keywords

Confounding factors (epidemiology); Instrumental variables

Indexed keywords

ARTICLE; CLINICAL RESEARCH; COMPARATIVE EFFECTIVENESS; COMPARATIVE STUDY; DRUG SAFETY; HEALTH CARE PERSONNEL; HOSPITAL ADMISSION; HUMAN; INSTRUMENTRUMENTAL VARIABLE METHOD; METHODOLOGY; OPERATION DURATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUBLICATION; RANDOMIZATION; STATISTICAL MODEL;

EID: 77953519101     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1908     Document Type: Article

References (72)

1. Newhouse JP, McClellan M. Econometrics in outcomes research: the use of instrumental variables. Annu Rev Public Health 1998; 19: 17-34.
2. Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol 2000; 29: 722-729.
3. Martens EP, Pestman WR, de Boer A, Belitser SV, Klungel OH. Instrumental variables: application and limitations. Epidemiology 2006; 17: 260-267.
4. Glymour MM. Natural experiments and instrumental variable analyses in social epidemiology. In Methods in Social Epidemiology, Oakes JM, Kaufman JS (eds). John Wiley and Sons: San Francisco, CA, 2006; 429-468.
5. Hernan MA, Robins JM. Instruments for causal inference: an epidemiologist's dream? Epidemiology 2006; 17: 360-372.
6. Grootendorst P. A review of instrumental variables estimation of treatment effects in the applied health sciences Health Serv Outcomes Res Methodol. 2007; 10: 159-179.
7. Angrist JD, Krueger AB. Instrumental variables and the search for identification: from supply and demand to natural experiments. J Econ Perspect 2001; 15: 69-85.
8. Goldberger AS. Structural equation methods in the social sciences. Econometrica 1972; 40: 979-1001.
9. Brookhart MA, Schneeweiss S, Rothman KJ, Glynn RJ, Avorn J, Sturmer T. Variable selection for propensity score models. Am J Epidemiol 2006; 163: 1149-1156.
10. Bound J, Jaeger DA, Baker RM. Problems with instrumental variables estimation when the correlation between the instruments and the endogeneous explanatory variables is weak. J Am Stat Assoc 1995; 90: 443-450.
11. Staiger D, Stock JH. Instrumental variables regression with weak instruments. Econometrica 1997; 65: 557-586. (Pubitemid 127466159)
12. Small DS, Rosenbaum P. War and wages: the strength of instrumental variables and their sensitivity to unobserved biases. J Am Stat Assoc 2008; 103: 924-933.
13. Robins JM. The Analysis of randomized and nonrandomized AIDS treatment trials using a new approach to causal inference in longitudinal studies. In Health Services Research Methodology: A focus on AIDS, Sechrest L, Freeman H, Mulley A (eds). U.S. Public Health Service: Washington, D.C, 1989; 113-159.
14. Manski CF. Nonparametric bounds on causal effects. Am Econ Rev 1990; 80: 319-323.
15. Balke A, Pearl J. Bounds on treatment effects from studies with imperfect compliance. J Am Stat Assoc 1997; 92: 1171-1176. (Pubitemid 127119877)
16. MacLehose RF, Kaufman S, Kaufman JS, Poole C. Bounding causal effects under uncontrolled confounding using counterfactuals. Epidemiology 2005; 16: 548-555.
17. Cheng J, Small DS. Bounds on causal effects in three-arm trials with noncompliance. J R Stat Soc B 2006; 68: 815-836.
18. Kaufman S, Kaufman JS, MacLehose RF. Analytic bounds on causal risk differences in directed acyclic graphs involving three binary variables. J Stat Plan Inference 2009; 139: 3473-3487.
19. Imbens GW, Angrist JD. Identification and estimation of local average treatment effects. Econometrica 1994; 62: 467-475.
20. Angrist JD, Imbens GW, Rubin DB. Identification of causal effects using instrumental variables. J Am Stat Assoc 1996; 81: 444-455. (Pubitemid 126412813)
21. Brookhart MA, Schneeweiss S. Preference-based instrumental variable methods for the estimation of treatment effects: assessing validity and interpreting results. Int J Biostat 2007; 3.
22. Wooldridge J. On two-stage least-squares estimation of the average treatment effect in a random coefficient model. Econ Lett 1997; 56: 129-133. (Pubitemid 127175187)
23. Heckman JJ, Urzua S, Vytlacil EJ. Understanding instrumental variable models with essential heterogeneity. NBER Working Pap 2006; 12: 574.
24. Basu A, Heckman JJ, Navarro-Lozano S, Urzua S. Use of instrumental variables in the presence of heterogeneity and self-selection: an application to treatments of breast cancer patients. Health Econ 2007; 16: 1133-1157.
25. McClellan M, McNeil BJ, Newhouse JP. Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables. JAMA 1994; 272: 859-866.
26. Brooks JM, Irwin CP, Hunsicker LG, Flanigan MJ, Chrischilles EA, Pendergast JF. Effect of dialysis center profit-status on patient survival: a comparison of risk-adjustment and instrumental variable approaches. Health Serv Res 2006; 41: 2267-2289.
27. McConnell KJ, Newgard CD, Mullins RJ, Arthur M, Hedges JR. Mortality benefit of transfer to level I versus level II trauma centers for head-injured patients. Health Serv Res 2005; 40: 435-457.
28. Pracht EE, Tepas JJ, 3rd, Langland-Orban B, Simpson L, Pieper P, Flint LM. Do pediatric patients with trauma in Florida have reduced mortality rates when treated in designated trauma centers? J Pediatr Surg 2008; 43: 212-221.
29. Wen SW, Kramer MS. Uses of ecologic studies in the assessment of intended treatment effects. J Clin Epidemiol 1999; 52: 7-12.
30. Earle CC, Tsai JS, Gelber RD,Weinstein MC, Neumann PJ,Weeks JC. Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis. J Clin Oncol 2001; 19: 1064-1070.
31. Brooks JM, Chrischilles EA, Scott SD, Chen-Hardee SS. Was breast conserving surgery underutilized for early stage breast cancer? Instrumental variables evidence for stage II patients from Iowa (erratum appears in Health Serv Res. 2004 Jun;39(3):693). Health Serv Res 2003; 38: 1385-1402.
32. Stukel TA, Fisher ES,Wennberg DE, Alter DA, Gottlieb DJ, Vermeulen MJ. Analysis of observational studies in the presence of treatment selection bias: effects of invasive cardiac management on AMI survival using propensity score and instrumental variable methods. JAMA 2007; 297: 278-285.
33. Johnston SC. Combining ecological and individual variables to reduce confounding by indication: case study - subarachnoid hemorrhage treatment. J Clin Epidemiol 2000; 53: 1236-1241.
34. Schneeweiss S, Seeger JD, Landon J, Walker AM. Aprotinin during coronary-artery bypass grafting and risk of death. N Engl J Med 2008; 358: 771-783.
35. Schmoor C, Caputo A, Schumacher M. Evidence from nonrandomized studies: a case study on the estimation of causal effects. Am J Epidemiol 2008; 167(9): 1120-1129.
36. Bradbury BD, Do TP, Winkelmayer WC, Critchlow CW, Brookhart MA. Greater Epoetin alfa (EPO) doses and short-term mortality risk among hemodialysis patients with hemoglobin levels less than 11 g/dL. Pharmacoepidemiol Drug Saf 2009; 18: 932-940.
37. Korn EL, Baumrind S. Clinician preference and the estimation of causal treatment effects. Stat Sci 1998; 13: 209-235. (Pubitemid 128466409)
38. Brookhart MA, Wang PS, Solomon DH, Schneeweiss S. Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Epidemiology 2006; 17: 268-275.
39. Wang PS, Schneeweiss S, Avorn J, et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005; 353: 2335-2341.
40. Schneeweiss S, Solomon DH, Wang PS, Rassen J, Brookhart MA. Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis. Arthritis Rheum 2006; 54: 3390-3398.
41. Cole JA, Norman H, Weatherby LB,Walker AM. Drug copayment and adherence in chronic heart failure: effect on cost and outcomes. Pharmacotherapy 2006; 26: 1157-1164.
42. Hennessy S, Leonard CE, Palumbo CM, Shi X, Ten Have TR. Instantaneous preference was a stronger instrumental variable than 3- and 6- month prescribing preference for NSAIDs. J Clin Epidemiol 2008; 61(12): 1285-1288.
43. Rassen JA, Brookhart MA, Glynn RJ, Mittleman MA, Schneeweiss S. Instrumental variables II: instrumental variable application-in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance. J Clin Epidemiol 2009; 62(12): 1233-1241.
44. Ho V, Hamilton BH, Roos LL. Multiple approaches to assessing the effects of delays for hip fracture patients in the United States and Canada. Health Serv Res 2000; 34: 1499-1518.
45. Ten Have tr Elliot MR, Joffe MM, Zanutto E, Datto C. Causal models for randomized physician encouragement trials in treating primary care depression. J Am Stat Assoc 2004; 99: 16-25.
46. Rosenstein AH, Shulkin D. Changing physician behavior is tool to reduce health care costs. Health Care Strateg Manage 1991; 9: 14-16.
47. White HD. Adherence and outcomes: it's more than taking the pills. Lancet 2005; 366: 1989-1991.
48. Brookhart MA, Patrick AR, Dormuth C, et al. Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol 2007; 166: 348-354.
49. Mamdani M, Juurlink DN, Kopp A, Naglie G, Austin PC, Laupacis A. Gastrointestinal bleeding after the introduction of COX 2 inhibitors: ecological study. BMJ (Clin Res) 2004; 328: 1415-1416. (Pubitemid 38789196)
50. Juurlink DN, Mamdani MM, Lee DS, et al. Rates of hyperkalemia after publication of the randomized aldactone evaluation study. N Engl J Med 2004; 351: 543-551.
51. Johnston KM, Gustafson P, Levy AR, Grootendorst P. Use of instrumental variables in the analysis of generalized linear models in the presence of unmeasured confounding with applications to epidemiological research. Stat Med 2008; 27: 1539-1556.
52. Cain LE, Cole SR, Greenland S, et al. Effect of highly active antiretroviral therapy on incident AIDS using calendar period as an instrumental variable. Am J Epidemiol 2009; 169: 1124-1132.
53. Shetty KD, Vogt WB, Bhattacharya J. Hormone replacement therapy and cardiovascular health in the United States. Med Care 2009; 47: 600-606.
54. Shea J. Instrument relevance in multivariate linear models: a simple measure. Rev Econ Statist 1997; 79: 348-352.
55. Walker AM. Confounding by indication. Epidemiology 1996; 7: 335-336.
56. Angrist JD, Krueger AB. Split-sample instrumental variables estimates of the return to schooling. J Bus Econ Stat 1995; 13.
57. Angrist JD, Imbens GW, Krueger AB. Jacknife instrumental variables estimation. J Appl Econometrics 1999; 14: 5767.
58. Baum CF, Schaffer ME, Stillman S. Instrumental variables and GMM: estimation and testing. Stata J 2003; 3: 1-31.
59. Sommer A, Zeger SL. On estimating efficacy from clinical trials. Stat Med 1991; 10: 45-52.
60. Cuzick J, Edwards R, Segnan N. Adjusting for non-compliance and contamination in randomized clinical trials. Stat Med 1997; 16: 1017-1029.
61. Robins JM. Correcting for non-compliance in randomized trials using structural nested mean models. Commun Stat Theory Methods 1994; 23: 2379-2412.
62. Bhattacharya J, Goldman D, McCaffrey D. Estimating probit models with self-selected treatments. Stat Med 2006; 25: 389-413.
63. Foster EM. Instrumental variables for logistic regression: an illustration. Soc Sci Res 1997; 26: 487-504.
64. Johnston SC, Henneman T, McCulloch CE, van der Laan M. Modeling treatment effects on binary outcomes with grouped-treatment variables and individual covariates. Am J Epidemiol 2002; 156: 753-760.
65. Rassen J, Schneeweiss S, Glynn RJ, Mittleman M, Brookhart MA. Instrumental variables methods for dichotomous outcomes. Am J Epidemiol 2009; 169(3): 273-284.
66. Angrist JD, Imbens GW. Two-stage least squares estimation of average causal effects in models with variable treatment intensity. J Am Stat Assoc 1995; 90: 431-442.
67. Durbin J. Errors in variables. Rev Int Stat Inst 1954; 22: 23-32.
68. Hausman JA. Specification tests in econometrics. Econometrica 1978; 46: 1251-1271.
69. Wu DM. Alternative tests of the independance between stochastic regessors and disturbances. Econometrica 1973; 41: 529-546.
70. Schneeweiss S, Setoguchi S, Brookhart A, Dormuth C, Wang PS. Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. CMAJ 2007; 176: 627-632.
71. Wang PS, Schneeweiss S, Setoguchi S, et al. Ventricular arrhythmias and cerebrovascular events in the elderly using conventional and atypical antipsychotic medications. J Clin Psychopharmacol 2007; 27: 707-710.
72. Brooks JM, Chrischilles EA. Heterogeneity and the interpretation of treatment effect estimates from risk adjustment and instrumental variable methods. Med Care 2007; 45: S123-S130.